FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 326:1533-1539 June 4, 1992 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND. The current clinical strategy for diagnosing genital herpes simplex virus (HSV) infection in women relies on clinical findings plus the selective use of viral culture. The effectiveness of this approach for identifying women with genital herpes is unknown. METHODS. We performed physical examinations, colposcopy, Pap smears, viral cultures, and HSV type-specific serologic assays of 779 randomly selected women attending a sexually transmitted disease clinic. RESULTS. Evidence of HSV type 2 infection was detected in 363 women (47 percent), and 9 others (1 percent) had positive cultures indicative of urogenital or anal infection with HSV type 1. Of these 372 women, only 82 (22 percent) had symptoms. Fourteen women (4 percent) had viral shedding without symptoms, 60 (16 percent) had formerly had symptomatic episodes, and 216 (58 percent) had antibodies to HSV-2 with neither viral shedding nor a history of clinical episodes. Characteristic ulcerations of the external genitalia were present in only two thirds of the 66 women with positive HSV cultures; the others had atypical genital lesions or asymptomatic viral shedding. Isolation of HSV from a genitourinary tract specimen was the most sensitive (77 percent) test for confirming a first episode of infection. The detection of HSV-2-specific antibodies was the most sensitive (97 percent) way to confirm symptomatic reactivations of HSV-2 infection. HSV-2 serologic testing also identified the 290 women with asymptomatic HSV-2 infections (37 percent), including 14 (5 percent) who were shedding virus asymptomatically on the day of the examination. CONCLUSIONS. The current strategy for diagnosing genital HSV infection in women misses many cases. Newly developed type-specific serologic methods can identify women with recurrent genital HSV-2 infection, as well as those with unrecognized or subclinical infection.

Source Information

Department of Epidemiology, School of Public Health, University of Washington, Seattle.

This article has been cited by other articles:

• Geretti, A M (2006). Genital herpes. Sex. Transm. Infect. 82: iv31-iv34 [Full Text]  
• Fife, K. H., Warren, T. J., Ferrera, R. D., Young, D. G., Justus, S. E., Heitman, C. K., Burroughs, S. M. (2006). Effect of Valacyclovir on Viral Shedding in Immunocompetent Patients With Recurrent Herpes Simplex Virus 2 Genital Herpes: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Mayo Clin Proc. 81: 1321-1327 [Abstract] [Full Text]  
• Patrick, D M, Rosenthal, S L, Stanberry, L R, Hurst, C, Ebel, C (2004). Patient satisfaction with care for genital herpes: insights from a global survey. Sex. Transm. Infect. 80: 192-197 [Abstract] [Full Text]  
• Kimberlin, D. W., Rouse, D. J. (2004). Genital Herpes. NEJM 350: 1970-1977 [Full Text]  
• Narouz, N, Allan, P S, Wade, A H, Wagstaffe, S (2003). Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK. Sex. Transm. Infect. 79: 35-41 [Abstract] [Full Text]  
• Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., Vandepapeliere, P., Dubin, G., the GlaxoSmithKline Herpes Vaccine Efficacy Study, (2002). Glycoprotein-D-Adjuvant Vaccine to Prevent Genital Herpes. NEJM 347: 1652-1661 [Abstract] [Full Text]  
• Schacker, T. W., Conant, M., Thoming, C., Stanczak, T., Wang, Z., Smith, M. (2002). Imiquimod 5-Percent Cream Does Not Alter the Natural History of Recurrent Herpes Genitalis: a Phase II, Randomized, Double-Blind, Placebo-Controlled Study. Antimicrob. Agents Chemother. 46: 3243-3248 [Abstract] [Full Text]  
• Opaneye, A A, Bashford, J (2002). Seroprevalence of antibodies to herpes simplex virus types 1 and 2 among two sexually active female populations in Middlesbrough, England. The Journal of the Royal Society for the Promotion of Health 122: 108-111 [Abstract]  
• Scoular, A (2002). Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex. Transm. Infect. 78: 160-165 [Abstract] [Full Text]  
• Narouz, N, Allan, P S, Wade, A H (2002). Genital herpes: general practitioners' knowledge and opinions. Sex. Transm. Infect. 78: 198-200 [Abstract] [Full Text]  
• Scoular, A, Gillespie, G, Carman, W F (2002). Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex. Transm. Infect. 78: 21-25 [Abstract] [Full Text]  
• Ribes, J. A., Hayes, M., Smith, A., Winters, J. L., Baker, D. J. (2001). Comparative Performance of Herpes Simplex Virus Type 2-Specific Serologic Assays from Meridian Diagnostics and MRL Diagnostics. J. Clin. Microbiol. 39: 3740-3742 [Abstract] [Full Text]  
• Ribes, J. A., Steele, A. D., Seabolt, J. P., Baker, D. J. (2001). Six-Year Study of the Incidence of Herpes in Genital and Nongenital Cultures in a Central Kentucky Medical Center Patient Population. J. Clin. Microbiol. 39: 3321-3325 [Abstract] [Full Text]  
• van Benthem, B H B, Spaargaren, J, van den Hoek, J A R, Merks, J, Coutinho, R A, Prins, M (2001). Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex. Transm. Infect. 77: 120-124 [Abstract] [Full Text]  
• Drake, S., Taylor, S., Brown, D., Pillay, D. (2000). Regular review: Improving the care of patients with genital herpes. BMJ 321: 619-623 [Full Text]  
• Goldman, B. D. (2000). Herpes Serology for Dermatologists. Arch Dermatol 136: 1158-1161 [Abstract] [Full Text]  
• Van Doornum, G. J. J., Slomka, M. J., Buimer, M., Groen, J., Van den Hoek, J. A. R., Cairo, I., Vyse, A., Brown, D. W. G. (2000). Comparison of a Monoclonal Antibody-Blocking Enzyme-Linked Immunoassay and a Strip Immunoblot Assay for Identifying Type-Specific Herpes Simplex Virus Type 2 Serological Responses. CVI 7: 641-644 [Abstract] [Full Text]  
• Corey, L., Handsfield, H. H. (2000). Genital Herpes and Public Health: Addressing a Global Problem. JAMA 283: 791-794 [Abstract] [Full Text]  
• Langenberg, A. G.M., Corey, L., Ashley, R. L., Leong, W. P., Straus, S. E., The Chiron HSV Vaccine Study Group, (1999). A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2. NEJM 341: 1432-1438 [Abstract] [Full Text]  
• Saiag, P., Praindhui, D., Chastang, C. (1999). A double-blind, randomized study assessing the equivalence of valacyclovir 1000 mg once daily versus 500 mg twice daily in the episodic treatment of recurrent genital herpes. J Antimicrob Chemother 44: 525-531 [Abstract] [Full Text]  
• Benedetti, J. K., Zeh, J., Corey, L. (1999). Clinical Reactivation of Genital Herpes Simplex Virus Infection Decreases in Frequency over Time. ANN INTERN MED 131: 14-20 [Abstract] [Full Text]  
• Mikloska, Z., Sanna, P. P., Cunningham, A. L. (1999). Neutralizing Antibodies Inhibit Axonal Spread of Herpes Simplex Virus Type 1 to Epidermal Cells In Vitro. J. Virol. 73: 5934-5944 [Abstract] [Full Text]  
• Ashley, R. L., Wald, A. (1999). Genital Herpes: Review of the Epidemic and Potential Use of Type-Specific Serology. Clin. Microbiol. Rev. 12: 1-8 [Abstract] [Full Text]  
• Blake, D. R., Duggan, A., Quinn, T., Zenilman, J., Joffe, A. (1998). Evaluation of Vaginal Infections in Adolescent Women: Can It Be Done Without a Speculum?. Pediatrics 102: 939-944 [Abstract] [Full Text]  
• Schacker, T., Ryncarz, A. J., Goddard, J., Diem, K., Shaughnessy, M., Corey, L. (1998). Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1-Infected Men. JAMA 280: 61-66 [Abstract] [Full Text]  
• Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., St. Louis, M. E. (1997). Herpes Simplex Virus Type 2 in the United States, 1976 to 1994. NEJM 337: 1105-1111 [Abstract] [Full Text]  
• Spruance, S. L., Tyring, S. K., DeGregorio, B., Miller, C., Beutner, K. (1996). A Large-Scale, Placebo-Controlled, Dose-Ranging Trial of Peroral Valaciclovir for Episodic Treatment of Recurrent Herpes Genitalis. Arch Intern Med 156: 1729-1735 [Abstract]  
• Wald, A., Zeh, J., Selke, S., Ashley, R. L., Corey, L. (1995). Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections. NEJM 333: 770-775 [Abstract] [Full Text]  
• Oliver, L., Wald, A., Kim, M., Zeh, J., Selke, S., Ashley, R., Corey, L. (1995). Seroprevalence of Herpes Simplex Virus Infections in a Family Medicine Clinic. Arch Fam Med 4: 228-232 [Abstract]  
• Cone, R. W., Hobson, A. C., Brown, Z., Ashley, R., Berry, S., Winter, C., Corey, L. (1994). Frequent Detection of Genital Herpes Simplex Virus DNA by Polymerase Chain Reaction Among Pregnant Women. JAMA 272: 792-796 [Abstract]  
• Celum, C. L., Coombs, R. W., Jones, M., Murphy, V., Fisher, L., Grant, C., Corey, L., Inui, T., Wener, M. H., Holmes, K. K. (1994). Risk Factors for Repeatedly Reactive HIV-1 EIA and Indeterminate Western Blots: A Population-Based Case-Control Study. Arch Intern Med 154: 1129-1137 [Abstract]  
• Braverman, P. K., Strasburger, V. C. (1994). Sexually Transmitted Diseases. CLIN PEDIATR 33: 26-37 [Abstract]